Directors dealings
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen" or "the Company")
DEALING IN SECURITIES BY DIRECTORS OF A MAJOR SUBSIDIARY
In compliance with paragraph 3.63 of the Listings Requirements of the
JSE Limited, disclosure is made of the following information:
Director : Trevor Ziman
Subsidiary Company : Aspen Asia Pacific Pty Limited
Date of transaction : 31 October 2012
Nature of transaction : Exercise of share appreciation
rights
Number of securities : 49,079
Class of securities : Ordinary shares
Grant price : R41.03
Exercise price : R149.99
Value of Transaction : R7 361 359.21
Nature of interest : Direct beneficial
Clearance obtained : Yes
Director : Gregory Lan
Subsidiary Company : Aspen Asia Pacific Pty Limited
Date of transaction : 31 October 2012
Nature of transaction : Exercise of share appreciation
rights
Number of securities : 49,079
Class of securities : Ordinary shares
Grant price : R41.03
Exercise price : R149.99
Value of Transaction : R7 361 359.21
Nature of interest : Direct beneficial
Clearance obtained : Yes
All exercises of share appreciation rights are deemed to be off-market
trades.
Durban
1 November 2012
Sponsor
Investec Bank Limited
Date: 01/11/2012 07:05:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.